Las Vegas, NV -- (SBWIRE) -- 01/08/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE), New York Mortgage Trust, Inc. (NASDAQ:NYMT), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) opened the session at $15.70, trading in a range of $15.20 - $18.62, and closed at $18.51. The stock showed a positive performance of +89.69% in the last trading session. The stock traded on a volume of 18.98 million shares and the average volume of the stock remained 563,232 million shares. Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.
Will NBIX Continue To Move Higher? Find Out Here
Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) traded 16.56 million shares in the last business day while the average volume of the stock remained 7.19 million shares. The stock showed a positive movement of +8.42% to end at $7.08. The 52 week range of the stock remained $1.62 - $8.77. Yingli Green Energy Holding Company Limited, together with its subsidiaries, engages in the design, development, manufacture, assembly, sale, and installation of photovoltaic (PV) products and related accessories worldwide. The company offers PV cells, PV modules, and integrated PV systems, as well as polysilicon ingots and blocks, and polysilicon wafers; and invests in renewable energy projects.
For How Long YGE will fight for Profitability? Read This Trend Analysis report
New York Mortgage Trust, Inc. (NASDAQ:NYMT) reported 14.80million shares were exchanged during the last trade, while the average volume is about 859,680 shares. The stock dropped -3.55% and finished the day at $6.79. The beta of the stock is recorded at 0.80. New York Mortgage Trust, Inc., a real estate investment trust (REIT), engages in acquiring, investing in, financing, and managing mortgage-related and financial assets in the United States. It primarily invests in residential mortgage-backed securities comprised of adjustable-rate, hybrid adjustable-rate.
Why Should Investors Buy NYMT After the Recent Fall? Just Go Here and Find Out
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) the stock decreased -1.47% and finished the session at $6.72. Traded with volume of 14.65 million shares in the prior session and the average volume of the stock remained 37.08 million shares. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine.
Will ARIA Get Buyers Even After The Recent Rally? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)